Croda International (LON:CRDA) Insider Stephen Oxley Acquires 4 Shares

Key Points

• Insider purchase: Stephen Oxley acquired 4 Croda International shares at GBX 3,218 each, worth £128.72. This follows two earlier small purchases but comes after his larger sale of 1,339 shares in August.
• Stock performance: Croda shares opened at GBX 3,207, with a 52-week range of GBX 2,478 to GBX 3,520.24 and a market capitalization of approximately £4.47 billion.
• Analyst outlook: The company has a consensus “Moderate Buy” rating and an average price target of GBX 3,490, supported by three Buy ratings and two Holds.

Croda International Plc (LON:CRDA - Get Free Report) insider Stephen Oxley bought 4 shares of Croda International stock in a transaction dated Thursday, September 10th. The stock was acquired at an average price of GBX 3,218 per share, with a total value of £128.72.

Stephen Oxley also recently made the following trade(s):

• On Monday, August 10th, Stephen Oxley acquired 5 shares of Croda International stock. The stock was acquired at an average cost of GBX 3,292 per share, with a total value of £164.60.
• On Monday, August 3rd, Stephen Oxley sold 1,339 shares of Croda International stock. The shares were sold at an average price of GBX 3,214, for a total value of £43,035.46.
• On Friday, July 10th, Stephen Oxley bought 5 shares of Croda International stock. The stock was bought at an average price of GBX 2,859 per share, with a total value of £142.95.

Croda International Price Performance

Shares of LON:CRDA opened at GBX 3,207 on Friday. The company has a current ratio of 2.57, a quick ratio of 2.25 and a debt-to-equity ratio of 36.06. Croda International Plc has a 1 year low of GBX 2,478 and a 1 year high of GBX 3,520.24. The business has a fifty day simple moving average of GBX 3,176.55 and a 200 day simple moving average of GBX 3,007.16. The firm has a market cap of £4.47 billion, a price-to-earnings ratio of 56.36, a P/E/G ratio of 1.40 and a beta of 0.92.

Croda International (LON:CRDA - Get Free Report) last posted its earnings results on Tuesday, July 28th. The company reported GBX 72.20 earnings per share (EPS) for the quarter. Croda International had a net margin of 4.61% and a return on equity of 3.65%. As a group, sell-side analysts predict that Croda International Plc will post 181.8307268 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft restated a "hold" rating and issued a GBX 3,300 price target on shares of Croda International in a research report on Wednesday, July 29th. Berenberg Bank reiterated a "buy" rating and issued a GBX 3,600 target price on shares of Croda International in a research note on Wednesday, July 29th. Citigroup lifted their target price on Croda International from GBX 3,050 to GBX 3,200 and gave the stock a "neutral" rating in a research report on Wednesday, July 29th. Finally, Jefferies Financial Group boosted their price target on Croda International from GBX 3,500 to GBX 4,000 and gave the company a "buy" rating in a research note on Tuesday, September 1st. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of GBX 3,490.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.